Endocrinologist and clinical trialist
Juan Pablo Frías, MD, FACE
50 pages reviewed
About
Juan Pablo Frías is a physician-scientist specializing in endocrinology, diabetes and metabolism. He is Medical Director and Principal Investigator at the Los Angeles Institute for Metabolic Research and Adjunct Clinical Professor of Medicine at Charles R. Drew University of Medicine and Science.
- Medical Director and Principal Investigator, Los Angeles Institute for Metabolic Research
- Adjunct Clinical Professor of Medicine, Charles R. Drew University of Medicine and Science
Pages reviewed
Most recent first- PeptideTirzepatideReviewed
- PeptideRetatrutideReviewed
- PeptideSemaglutideReviewed
- PeptideBPC-157Reviewed
- PeptideGHK-CuReviewed
- PeptideSermorelinReviewed
- PeptideTesamorelinReviewed
- PeptideMOTS-cReviewed
- PeptideTB-500Reviewed
- PeptideCJC-1295Reviewed
- PeptideKPVReviewed
- PeptidePT-141Reviewed
- PeptideMelanotan IIReviewed
- PeptideAOD-9604Reviewed
- PeptideIGF-1 LR3Reviewed
- PeptideSelankReviewed
- PeptideSemaxReviewed
- PeptideCagrilintideReviewed
- PeptideSS-31Reviewed
- PeptideKLOWReviewed
- PeptideGLOWReviewed
- PeptideWolverineReviewed
- PeptideCJC-1295 + IpamorelinReviewed
- PeptideEnclomipheneReviewed
- PeptideHGHReviewed
- PeptidehCGReviewed
- PeptideKisspeptin-10Reviewed
- PeptideThymosin Alpha-1Reviewed
- Peptide5-Amino-1MQReviewed
- PeptideSLU-PP-332Reviewed
- PeptideIpamorelinReviewed
- PeptideOrforglipronReviewed
- PeptideEpitalonReviewed
- PeptideDSIPReviewed
- PeptideDihexaReviewed
- PeptideOxytocinReviewed
- PeptideSurvodutideReviewed
- PeptideCagriSemaReviewed
- PeptideMazdutideReviewed
- PeptideLL-37Reviewed
- PeptideARA-290Reviewed
- PeptideVIPReviewed
- GuideHow to reconstitute peptides: the math, step by stepReviewed
- GuideBacteriostatic water: what it is and how it differs from sterile waterReviewed
- GuideHow to read an insulin syringe: units, mL and tick marksReviewed
- GuideWhat are peptides? A plain-English guideReviewed
- GuideAre peptides legal? FDA status in 2026, explainedReviewed
- GuideRetatrutide explained: what it is, trial status and what is still unknownReviewed
- GuideThe GLP-1 pipeline in 2026: approved drugs and what is in trialsReviewed
- GuideHow we test our data before it reaches a pageReviewed